Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS
Author(s) -
Anna Katarina HjorthHansen,
Øyvind Salvesen,
Liv Guro Engen Hanem,
Torbjørn Moe Eggebø,
Kjell Å. Salvesen,
Eszter Vanky,
Rønnaug Ødegård
Publication year - 2017
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-01191
Subject(s) - offspring , medicine , placebo , metformin , birth weight , body mass index , pregnancy , population , polycystic ovary , overweight , obstetrics , gestational age , endocrinology , gestation , anthropometry , obesity , biology , insulin resistance , diabetes mellitus , genetics , alternative medicine , environmental health , pathology
Metformin is used in an attempt to reduce pregnancy complications associated with polycystic ovary syndrome (PCOS). Little is known about the effect of metformin on fetal development and growth.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom